All Sites This Site

Find a Program

Find a Lab

MESSAGE FROM THE CHIEF

John P. Roberts, MD


John P. Roberts, M.D.

Professor & Chief,
Division of Transplant Surgery

 

Read message »

Make a Gift

A gift to the Dept of Surgery
helps us discover new
treatments and cures.

 

Read more »

Celebrating 10,000 patients & years of sharing
Transplant Surgery »  Faculty »  Peter G. Stock, M.D., Ph.D.

Peter G. Stock, M.D., Ph.D.

Professor of Surgery

Surgical Director, Pediatric Renal Transplantation Program

Surgical Director, Pancreas Transplant Program

Contact Information

(415) 353-1888 Clinical, Liver

(415) 353-1551 Clinical, Kidney and Pancreas

(415) 353-8617 Academic

stockp@surgery.ucsf.edu

Education

  • University of Illinois, Urbana, IL, B.S., Biology, 1974-78
  • University of Illinois, Chicago, IL, M.D., Medicine, 1978-82
  • University of Minnesota, Minneapolis, MN, Ph.D., Surgery, 1985-92

Residencies

  • University of Minnesota, Intern, General Surgery, 1982-83
  • University of Minnesota, Resident, General Surgery, 1983-90

Fellowships

  • University of California, San Francisco, Fellow, Transplant Surgery, 1990-92

Postdoctoral Training

Board Certification

  • American Board of Surgery, 1991

Program Affiliations

Clinical Expertise

  • Pancreas Transplantation
  • Pancreatic Islet Cell Transplantation
  • Kidney and Liver Transplantation in HIV-infected Patients
  • Pediatric Renal Kidney Transplantation

Research Interests

  • Beta cell replacement for the treatment of Type I diabetes mellitus.
  • Determining the safety and efficacy of solid organ transplantation in people with HIV.
  • Novel immunosuppressive regimens with co-stimulatory blockade to prevent the immune response.
  • Immune monitoring to assess the efficacy of immunosuppressive therapy against the alloimmune and recurrent autoimmune response.
  • Strategies to increase the source of beta cells.

Website LInks

Biography

Dr. Peter Stock is Professor of Surgery and a multi-organ transplant surgeon at the University of California, San Francisco. He heads up the Solid Organ Pancreas Transplant Program as well as the Pancreatic Islet Cell Program. He is the Surgical Director of the Pediatric Renal Transplant Program. Dr. Stock is clinically active in liver, kidney and pancreas transplantation. Dr. Stock's current basic science research interests involve the induction of transplantation tolerance to block both alloimmunity as well as recurrent autoimmunity following pancreatic islet transplantation. Finally, he is the principal investigator on a study to determine the safety and efficacy of solid organ transplantation in the HIV positive recipient.

Selected Publications

  1. Chang GJ, Liu T, Feng S, Bedolli M, O'Rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery. 132:149-56, Aug/2002.
  2. Roland ME, Lo B, Braff J, Stock PG. Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med. 163:1773-8, 2003.
  3. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 76: 370-5, Jul/27/2003.
  4. Freise CE, Kang SM, Feng S, Hirose R, Stock P. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg. 138:1121-5; discussion 1125-6, Oct/2003.
  5. Stock PG, Bluestone JA. Beta-cell replacement for type I diabetes. Annu Rev Med. 55:133-56, 2004.